Navigation Links
MonoSol Rx Completes Thin Film Escitalopram Oxalate Pilot Product Development
Date:8/4/2008

ate in competitive markets while offering unique advantages over drugs dosed by traditional tablets, capsules and ODTs.

About PharmFilm(R)

PharmFilm(R) is a proprietary drug delivery technology that utilizes a novel process and encapsulation compositions to develop easy to use, taste- masked, quick dissolving thin-film drug formulations. PharmFilm(R) delivers a convenient efficacious dose of drug that in some instances can deliver improved therapeutics. PharmFilm's drug delivery advantages significantly benefits patients and their prescribing physicians, and helps improve compliance in pediatric, elderly and other patients who have difficulty swallowing traditional dosage forms.

Media / Investors:

The Ruth Group

Jason Rando / Sara Ephraim

(646) 536-7025 / 7004

jrando@theruthgroup.com

sephraim@theruthgroup.com

Contact:

MonoSol Rx

Keith Kendall

Chief Financial Officer

(732) 564-5000


'/>"/>
SOURCE MonoSol Rx
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. MonoSol Rx Completes Thin Film Ondansetron Pilot Bioequivalence Study
2. Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders
3. NicOx Completes Enrollment of Two Ambulatory Blood Pressure Measurement (ABPM) Studies for Naproxcinod in Hypertensive OA Patients
4. VIA Pharmaceuticals Completes Patient Visits in Phase 2 Carotid Endarterectomy (CEA) Trial
5. Portola Completes $60 Million Financing to Advance Its Therapeutic Programs
6. Pulmo BioTech Inc. Completes Bio-Distribution Studies
7. Isolagen Completes Pivotal Efficacy Portion of Phase III Studies of Isolagen Therapy(TM) for Wrinkles
8. Neurocrine Biosciences Completes Petal Study Treatment Phase for Endometriosis
9. Metabolex Completes Patient Enrollment in Phase 2 Trial of MBX-8025 for Treatment of Dyslipidemia
10. ChemoCentryx Completes Enrollment of PROTECT-1, a Phase II/III Clinical Trial of CCR9 Antagonist CCX282-B (Traficet-EN(TM)) in Crohns Disease
11. Pharmaxis Long-Term Safety Study of Bronchitol Completes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... , Aug. 28, 2015 ... announced the addition of the "Investigation Report ... their offering. Developed by Pharmacia & ... receptor agonist which effectively reduces intraocular pressure. As ... latanoprost (under the trade name of Xalatan) entered ...
(Date:8/28/2015)... , August 28, 2015 The ... in collaboration with one of the leading academics in the ... (current world record holder in life extension for model animals ... into biology of aging and age-related diseases, primarily, around the ... work has just been published as "Stability analysis of a ...
(Date:8/28/2015)... 28, 2015 Perrigo Company plc ("Perrigo") (NYSE: ... N.V. ("Mylan") (NASDAQ: MYL ) shareholder vote regarding ... "Our views of Mylan,s offer to Perrigo shareholders have ... our Board,s careful reflection of the value available to ... choices that Mylan has allowed its shareholders to consider," ...
Breaking Medicine Technology:China Latanoprost Market Investigation Report 2015-2019 2Gero: Physics Meets Biology to Help Defeat Aging 2Gero: Physics Meets Biology to Help Defeat Aging 3Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 2Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 3Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 4Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 5
... 8, 2011 Reportlinker.com announces that a new ... Europe Drug Delivery Devices Market ... Europe Drug Delivery Devices Market ... GlobalData,s new report, "Europe Drug Delivery ...
... June 8, 2011 Edison Pharmaceuticals, Inc. announced ... has granted orphan drug designation to EPI-743 for ... these mitochondrial diseases affect an estimated 60,000 individuals. ... 1982, provides incentives for companies to pursue treatments ...
Cached Medicine Technology:Reportlinker Adds Europe Drug Delivery Devices Market Outlook to 2017 2Edison Pharmaceuticals Announces FDA Grants EPI-743 Orphan Drug Designation 2
(Date:8/29/2015)... ... August 29, 2015 , ... People who have heart or ... or asthma, are at higher risk from wildfire smoke especially in Calgary, Alberta.Those ... heart-rhythm problems (arrhythmia or irregular heartbeat) are also sensitive to air pollution. ...
(Date:8/29/2015)... ... August 29, 2015 , ... Vascular Health Sciences ... sell Arterosil and Arterosil HP, and that all claims and counterclaims have been ... Sciences, LLC (VHS) in the United States District Court for the Southern District ...
(Date:8/28/2015)... ... August 28, 2015 , ... An online provider of CPAP machines, masks, supplies, ... CPAP equipment more affordable by offering shipping at no cost to you, directly to ... orders of any size. My Cpap Store is located in Las Vegas, Nevada. , ...
(Date:8/28/2015)... ... 28, 2015 , ... An article published August 19th by the ... gone through to open a pizzeria in Westchester. Mr. LaRocco was aware from opening ... months, but the current process, having already gone on for over a year, is ...
(Date:8/28/2015)... Falls Church, VA (PRWEB) , ... ... ... and Cybersecurity Risk Management for Medical Devices:, Understanding the FDA’s Position and ... – Rockville, MD, http://www.fdanews.com/cybersecuritymd , This workshop, chaired by internationally ...
Breaking Medicine News(10 mins):Health News:Heart Fit Clinic Sounds the Alarm on Forest Fire Smoke and Chronic Heart Disease in Calgary Area 2Health News:My Cpap Store Now Offering Delivery Special 0 Cost to You 2Health News:Article on Building Approval Process for LA Business Highlights the Need for a Bridge Between Businesses and City Officials, says Fire Protection Group Inc. 2Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 2Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 3Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 4Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 5
... ventromedial prefrontal cortex may be associated with how people ... event.// ,Researchers from Massachusetts General Hospital have ... factor that affects the incidence of people developing anxiety ... , ,People who go through an intense and ...
... death was reported after being given an unauthorized Hepatitis A ... province of Anhui were administered the Hepatitis A vaccine on ... ,Li Wei a six-year-old child suffered an unspecified infection ... following which she died a few days later. Some of ...
... risk of cellular rejection after a heart transplant// ... ,The drug, a humanized monoclonal antibody, is directed ... ,Patients who were taken into the Study ... ,The primary endpoint was a composite of moderate ...
... 75 million people in the United States, Europe and Japan ... recommended that drinking calcium water may help in reducing osteoporosis., ... majority of the people do not consume enough of this ... individuals with osteoporosis but for many teenagers, and those in ...
... People who remain angry for considerable periood of time may ... ,Reserachers of University of California, Berkeley, had found that feeing ... like lowering of the immune functions, urge to pick up ... life. ,Reserachers who had done a survey of the ...
... consumption of fruits, vegetables and foods high in fibre can ... heart disease. ,Western cuisines are not so high in ... in the diet. ,10 healthy individuals were taken as ... of them. The diets were a vegetarian diet rich in ...
Cached Medicine News:Health News:Fibre Rich Food A Boon For Lowering Cholesterol 2
... Innovators in Anesthesia and Respiratory Products, ... medical devices for Anesthesia and Respiratory professionals. ... products that enhance the clinician's ability to ... attention to the bottom line. , ...
... Innovators in Anesthesia and Respiratory Products, ... quality medical devices for Anesthesia and Respiratory ... manufacture products that enhance the clinician's ability ... close attention to the bottom line. , ...
... optimum lung penetration for maximum therapeutic benefit. ... µ at 6-8 LPM. Latex-free components. Usable ... the world leader in airway management products, ... proven technology by offering top brands in ...
... makeshift, modified nebulizer setups to deliver CNT ... when your patient is critical? OMNI~MAX has ... in Heliox rescue therapy. In severe obstructive ... standard of care in hospitals across the ...
Medicine Products: